Progression-free survival as a potential surrogate endpoint for overall survival after conversion therapy for unresectable hepatocellular carcinoma (GUIDANCE008)

J Jian-Hong Zhong L Liang Ma B Bang-De Xiang D Da-Long Yang A Ai-Qun Liu Y Ya-Qun Yu L Lin Ye S Shu-Qun Li S Shao-Ping Liu Z Zhen Liu C Chuang Qin Z Zhi-Jun Jiang N Ning Peng J Jia-Liang Wei Z Ze Su J Jun-Liang Nong Y Yi-He Yan K Kang Chen (Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Key Laboratory for Ultrafine Materials of Ministry of Education, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Engineering Research Center for Biomedical Materials of Ministry of Education, School of Materials Science and Engineering) X Xiao-Feng Dong Y Yong-Yu Yang J Jun-Jie Ou S Shu-Chang Chen Y Ying Xue Wu H Hong-Bing Yao X Xue-Yao Wang F Fan-Jian Zeng J Jie Liu M Mian-Jing Li P Pei-Sheng Wu Y Yong-Rong Liang Y Yao-Zhi Chen Y Yong-Cheng Lai M Ming-Song Wu W Wen-Feng Li T Tian-Man Li F Fu-Quan Yang Z Zhi-Yin Liang T Teng-Meng Zhong X Xian-Shuang Mao F Fu-Xin Li T Teng-Xian Zhou G Guang-Cai Zheng Y Yao-Ming Wang M Min Luo (College of Life Sciences, Anhui Normal University) G Guo-dong Wang Q Qing-Qing Pang X Xiao-Kai Shen L Lei Liu S Si-Cong Lu W Wen-Hai He X Xian-Jian Wu L Lin-Hong Xie J Jian-Yuan Meng Z Zhi-Cheng Li T Ting Quan J Jin-Wei Wu P Ping Cen